Trends

Few medical symptoms generate as much immediate alarm for patients—and as much diagnostic ambiguity for clinicians—as a suddenly inflamed eye....

The most ambitious idea in modern medicine may no longer be curing disease but postponing it. Search interest around longevity...

Employer-sponsored health insurance covers roughly half of the United States population, which means that many of the country’s most consequential...

Retatrutide’s clinical profile—substantial weight loss, improved glycemic control, shifts in lipid parameters—suggests downstream effects that extend beyond obesity. In Phase...

Search patterns around functional longevity programs, mobility preservation clinics, cognitive optimization protocols, and lifespan-extension investment vehicles have intensified across healthcare...

A decision about a peptide protocol rarely begins in a clinic. It begins in a search bar, a group chat,...

The quiet revolution began in the cafeteria. Employers analyzing aggregate nutrition data alongside GLP‑1 prescription trends are discovering that pharmacologic...

Some drugs change physiology. Others change the grammar of healthcare economics. Retatrutide, the experimental triple agonist drawing sustained attention across...

The surge of interest surrounding GLP‑1 receptor agonists and related metabolic therapies has rapidly transformed the landscape of obesity medicine....

The modern enthusiasm surrounding biomarker testing and preventive diagnostics reflects a growing conviction that disease can be intercepted long before...

Testosterone replacement therapy and broader hormone optimization have migrated from endocrinology clinics into subscription platforms, influencer podcasts, and venture-backed telehealth...

  The gut-brain axis—once a niche topic in neurogastroenterology and mucosal immunology—is now a staple of TikTok explainers and supplement...